Dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride and what is the scope of freedom to operate?
Dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride
US Patents and Regulatory Information for dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-002 | Nov 30, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-001 | Nov 30, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-002 | Nov 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-001 | Nov 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-002 | Nov 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | EMBOLEX | dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride | INJECTABLE;INJECTION | 018885-001 | Nov 30, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |